Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial. (linkinghub.elsevier.com)

Authors: Jittamala P … White NJ Journal: Lancet Infectious Diseases Published: 2026-07-28 DOI: https://doi.org/10.1016/S1473-3099(26)00255-0